iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)																			1 Months Ended		2 Months Ended	3 Months Ended		4 Months Ended	6 Months Ended			8 Months Ended	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jan. 11, 2021	Dec. 10, 2020	Dec. 08, 2020	Nov. 25, 2020	Jun. 30, 2020	Jun. 30, 2020	Jun. 17, 2020	May 13, 2020	Mar. 19, 2020	Oct. 31, 2019	Oct. 29, 2019	Oct. 28, 2019	Jun. 26, 2018	Nov. 27, 2017	Feb. 23, 2017	Apr. 13, 2016	Apr. 07, 2016	Jan. 13, 2016	Aug. 31, 2020	Jul. 27, 2020	Dec. 31, 2019	Jun. 30, 2020	Dec. 31, 2019	Jul. 27, 2020	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2020	Feb. 20, 2020	Sep. 30, 2019	Jun. 20, 2018	Dec. 19, 2017	Dec. 31, 2015
Stockholders' Equity [Line Items]
Proceeds from offering				$ 72,000,000							$ 4,500,000
Cost on issuance of shares																									$ 4,642,000		$ 60,000
Deemed dividends on common stock recognized																							$ 21,560,000
Warrants to purchase shares of Common Stock																																9,595,002
Exercise of warrants										29,100,000											29,100,000					29,100,000	14,999,998
Proceeds from exercise of warrants																									$ 0		$ 691,000	$ 6,400,000	$ 6,300,000
Shares of common stock issued for the cashless exercise of Warrants																												5,900,000
Cashless exercise of warrants reducing balance owed for notes payable - warrant exchange																												$ 1,300,000
Costs related to the warrant exchange offset against additional paid-in capital																												$ 313,000
Warrants outstanding					0	0																0			0	0		0	0
Preferred Stock, Shares Authorized					1,000,000	1,000,000																1,000,000			1,000,000	1,000,000		1,000,000	1,000,000
Common Stock, Par or Stated Value Per Share					$ 0.001	$ 0.001																$ 0.001			$ 0.001	$ 0.001		$ 0.001	$ 0.001
Cost for issuance of shares																									$ 4,642,000		60,000
Sale of Stock, Consideration Received on Transaction											4,500,000
Common Stock, Shares Authorized					275,000,000	275,000,000																275,000,000			275,000,000	275,000,000		275,000,000	275,000,000
Proceeds from Issuance of Common Stock				$ 72,000,000							4,500,000
Common Stock, Shares, Issued					140,071,110	140,071,110																140,071,110			211,769,103	140,071,110		140,071,110	140,071,110
Proceeds from Warrant Exercises																									$ 0		$ 691,000	$ 6,400,000	$ 6,300,000
Stock Issued During Period, Shares, Warrants Exercised										29,100,000											29,100,000					29,100,000	14,999,998
Number of shares issued during the period				30,184,399
Gross proceeds from issuance of common stock				$ 72,000,000							$ 4,500,000
Net Proceeds From Issuance Of Common Stock				68,800,000
Sales Agreement
Stockholders' Equity [Line Items]
Aggregate offering price				100,000,000
Aggregate Common Stock Purchased				$ 100,000,000
Underwriting Agreement
Stockholders' Equity [Line Items]
Number of shares agreed to be issued			29,661,017
Shares Issued, Price Per Share		$ 1.0955
Sale Of Stock Number Of Shares Offered For Sale			29,661,017
Number of shares issued during the period		29,661,017
Net Proceeds From Issuance Of Common Stock		$ 32,300,000
Series A Warrants [Member]
Stockholders' Equity [Line Items]
Exercise of warrants																											3,300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.22
Number of stocks sold											1
Number of warrants issued											25,000,000
Exercise price of warrants											$ 0.22
Term of the warrants											2 years
Stock Issued During Period, Shares, Warrants Exercised																											3,300,000
Number of shares issued during the period											25,000,000
Series B Warrants [Member]
Stockholders' Equity [Line Items]
Exercise of warrants																											6,600,000
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.22
Number of stocks sold											1
Number of warrants issued											25,000,000
Exercise price of warrants											$ 0.22
Term of the warrants											7 years
Stock Issued During Period, Shares, Warrants Exercised																											6,600,000
Number of shares issued during the period											25,000,000
Common Stock
Stockholders' Equity [Line Items]
Exercise of warrants																							3,140,000
Shares Issued, Price Per Share											$ 0.20																							$ 0.90
Conversion of Stock, Shares Issued																			28,925,000						5,887,997			22,550,000		2,470,000
Common Stock, Shares Authorized																																			275,000,000
Shares, Outstanding					140,071,000	140,071,000															54,567,000	140,071,000	54,567,000		211,769,000	140,071,000	54,567,000	140,071,000	140,071,000	20,152,000	180,318,000		24,152,000
Number of stock issued on each unit of stock sold											1
Stock Issued During Period, Shares, Warrants Exercised																							3,140,000
Number of shares issued during the period											2,450,000
Preferred Tracking Stock
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Acquisitions															1
Shares exchanged for ownership interest															29,990,000
Noncontrolling Interest, Amount Represented by Preferred Stock															$ 13,000,000
Preferred Stock, Dividend Rate, Percentage																									2.00%
Preferred Stock, Dividends Per Share, Declared																									$ 0
Dividends Payable					$ 871,000	$ 871,000																$ 871,000			$ 1,002,000	$ 871,000		$ 871,000	$ 871,000
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Exercise of warrants																							0
Shares, Outstanding					6,000	6,000															6,000	6,000	6,000			6,000	6,000	6,000	6,000	10,000			6,000
Stock Issued During Period, Shares, Warrants Exercised																							0
Warrant [Member]
Stockholders' Equity [Line Items]
Number of stocks sold											2
Common Stock and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share											$ 0.20
Preferred Tracking Stock
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															1
Preferred Stock, Par or Stated Value Per Share															$ 0.001
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized																																		1,000,000
Convertible Preferred Stock, Terms of Conversion																									Each share of Series A Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019
Dividends Payable																									$ 0
Preferred Stock, Par or Stated Value Per Share																																		$ 0.001
Conversion of Stock, Shares Converted																													3,987	2,223
Preferred Stock, Shares Outstanding					0	0																0			0	0		0	0
Share Price											$ 1,000
Number of shares issued during the period													6,300
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage											48.00%
Preferred Stock, Shares Authorized					5,785	5,785																5,785			5,785	5,785		5,785	5,785					1,000,000
Convertible Preferred Stock, Terms of Conversion																									Each share of Series B Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the section below entitled "Public Offering - October 29, 2019" for further information. The number of shares of common stock to be received was limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series B Preferred would not have the right to exercise any portion of its Series B Preferred if such holder, together with its affiliates, would beneficially own over 48% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Dividends Payable																									$ 0
Preferred Stock, Par or Stated Value Per Share																																		$ 0.001
Shares Issued, Price Per Share											$ 0.20																							$ 0.90
Conversion of Stock, Shares Converted						5,785							5,785
Preferred Stock, Shares Outstanding					5,785	5,785																5,785			0	5,785		5,785	5,785
Share Price											$ 1,000
Series C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage												4.99%
Preferred Stock, Shares Authorized												1,000,000
Convertible Preferred Stock, Terms of Conversion																									Each share of Series C Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.20, subject to adjustment. The number of shares of common stock to be received was limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series C Preferred would not have the right to exercise any portion of its Series C Preferred if such holder, together with its affiliates, would beneficially own over 4.99% (or, upon election by a holder prior to the issuance of any Series C Preferred Shares, 9.99%) of the number of shares of our common stock outstanding immediately after giving effect to such exercise; provided, however, that upon prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99% and any such increase would not be effective until the 61st day after such notice was delivered to the Company.
Dividends Payable												$ 0
Preferred Stock, Par or Stated Value Per Share												$ 0.001
Common Stock, Par or Stated Value Per Share												1,000
Shares Issued, Price Per Share												$ 0.20
Conversion of Stock, Shares Converted											4,510
Preferred Stock, Shares Outstanding					0	0																0			0	0		0	0
Maximum ownership through conversion without prior notice, prior to the issuance of preferred shares												9.99%
Number of shares issued during the period											4,510
Series C Preferred Shares, and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share											$ 1,000
Over allotment \| Underwriting Agreement
Stockholders' Equity [Line Items]
Number of shares agreed to be issued			4,449,152
Sale Of Stock Number Of Shares Offered For Sale			4,449,152
Underwritten offering
Stockholders' Equity [Line Items]
Proceeds from offering		35,200,000									$ 5,000,000
Cost on issuance of shares		2,900,000
Cost for issuance of shares		2,900,000
Proceeds from Issuance of Common Stock		35,200,000									5,000,000
Gross proceeds from issuance of common stock		$ 35,200,000									$ 5,000,000
Subsequent event \| Over allotment \| Underwriting Agreement
Stockholders' Equity [Line Items]
Number of shares issued during the period	4,240,828
Net Proceeds From Issuance Of Common Stock	$ 4,700,000
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Term of agreement													2 years			3 years
Maximum Common Stock Percentage													48.00%	38.00%				38.00%
Proceeds from exercise of warrants																		$ 945,000
Stock Issued During Period, Shares, Acquisitions																		350,000
Shares Issued, Price Per Share																		$ 6.22
Stock Issued During Period, Value, New Issues																$ 4,043,000		$ 2,177,000
Equity Method Investment, Ownership Percentage														40.00%
Agreement term													2 years			3 years
Class Of Warrants Or Rights Exercised																		178,400
Proceeds from Warrant Exercises																		$ 945,000
Number of shares issued during the period																650,000	650,000	650,000
iBio CDMO LLC
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															1
Eastern Affiliate
Stockholders' Equity [Line Items]
Equity Method Investment, Ownership Percentage													40.00%
Number of shares issued during the period																		650,000
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Proceeds from offering																						$ 18,400,000
Proceeds from Issuance of Common Stock																						18,400,000
Gross proceeds from issuance of common stock																						$ 18,400,000
Preferred Tracking Stock
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues															$ 13,000,000
UBS Securities, LLC ("UBS")
Stockholders' Equity [Line Items]
Proceeds from offering					$ 37,800,000	$ 5,500,000																			$ 28,400,000
Cost on issuance of shares					1,300,000																				1,700,000
Cost for issuance of shares					1,300,000																				1,700,000
Commission rate							3.00%
Reimbursement of fees and disbursements							$ 50,000
Sale of Stock, Consideration Received on Transaction							72,000,000
Proceeds from Issuance of Common Stock					$ 37,800,000	$ 5,500,000																			$ 28,400,000
Number of shares issued during the period					17,420,000	2,360,000																			10,410,000
Gross proceeds from issuance of common stock					$ 37,800,000	$ 5,500,000																			$ 28,400,000
iBio CMO
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															29,990,000
Noncontrolling Interest, Amount Represented by Preferred Stock																		$ 15,000,000
Noncontrolling Interest, Ownership Percentage by Parent															99.99%																					100.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners																		70.00%							30.00%
iBio CMO \| Preferred Tracking Stock
Stockholders' Equity [Line Items]
Acquisition Of Equity Interest, Units Receivable Per Preferred Share																									29,990,000
iBio CMO \| Preferred Tracking Stock \| Scenario Two
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															29,990,000
iBio CMO \| Eastern Affiliate
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners															0.01%										70.00%
Preferred Tracking Stock
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues															$ 13,000,000
Convertible Preferred Stock, Shares Issued upon Conversion															29,990,000
Lincoln Park 2020 Purchase Agreement
Stockholders' Equity [Line Items]
Term of agreement									36 months
Aggregate offering price									$ 50,000,000
Number of shares agreed to be issued									1,000,000
Proceeds from offering																				$ 6,800,000				$ 25,200,000
Maximum obligation under each Regular Purchase									$ 5,000,000
Floor price									$ 0.20
Maximum Common Stock Percentage									19.99%
Common Stock, Par or Stated Value Per Share									$ 0.001
Shares Issued, Price Per Share								$ 1.09
Maximum ownership through conversion without prior notice									9.99%
Stock Issued During Period, Value, New Issues								$ 1,100,000
Proceeds from Issuance of Common Stock																				$ 6,800,000				$ 25,200,000
Aggregate Common Stock Purchased									$ 50,000,000
Agreement term									36 months
Sale Of Stock Number Of Shares Offered For Sale									1,000,000
Number of shares issued during the period								1,000,000	815,827											2,673,000		16,800,000		19,470,000
Gross proceeds from issuance of common stock																				$ 6,800,000				$ 25,200,000
Net Proceeds From Issuance Of Common Stock							$ 68,830,000																		$ 107,600,000
Lincoln Park 2020 Purchase Agreement \| Common Stock
Stockholders' Equity [Line Items]
Net Proceeds From Issuance Of Common Stock																									$ 4,700,000
Linco ln Park May 2020 Purchase Agreement \| Securities and Exchange Commission
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share								$ 1.09
Stock Issued During Period, Value, New Issues								$ 1,090,000
Number of shares issued during the period								1,000,000